
- Pharmaceutical Technology-09-02-2020
- Volume 44
- Issue 9
Oral Solid Dosage Equipment
GEA has expanded, integrated, and consolidated its ConsiGma continuous oral solid dosage equipment, allowing fully configurable systems that can be connected to new or existing facilities, including third-party equipment.
GEA has expanded, integrated, and consolidated its ConsiGma continuous oral solid dosage equipment, allowing fully configurable systems that can be connected to new or existing facilities, including third-party equipment.
The newly defined ConsiGma 4.0 modules can be used to transform an individual unit operation (e.g., granulation) from batch to a stand-alone, continuous operation. The system uses advanced process control software and the company’s newly developed Conductor 4.0 control system, which is compatible with supervisory control and data acquisition systems and connects to the Industrial Internet of Things.
Although the system is configurable, standard, core elements are available “off-the-shelf.” Standardization or mass customization makes continuous manufacturing equipment more affordable for a wider range of users and expedites delivery.
Articles in this issue
about 4 years ago
Moving Forward in Serializationabout 5 years ago
Preparing Pandemic Vaccine Capacityabout 5 years ago
Tracking API Quality During a Pandemicabout 5 years ago
Capsule Innovations: Speeding Up Drug Developmentabout 5 years ago
Manufacturing Drug–Device Combination Productsabout 5 years ago
Advancing Understanding of a Traditional Techniqueabout 5 years ago
Pharmacovigilance Under Scrutiny: Why Companies are Falling Shortabout 5 years ago
Pharmacopoeia Compliance: A Practical Guideabout 5 years ago
Streamlining Method Transfer Across Global SitesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





